Next Article in Journal
Erratum: Gu, S. et al. Error-Free Bypass of 7,8-dihydro-8-oxo-2′-deoxyguanosine by DNA Polymerase of Pseudomonas aeruginosa Phage PaP1. Genes 2017, 8, 18
Previous Article in Journal
Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)
Previous Article in Special Issue
MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype
Open AccessReview

Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance

by 1,2,* and 3,4
1
Centre for Molecular Medicine and Biobanking, University of Malta, Msida MSD2080, Malta
2
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M1 7DN, UK
3
Center for Medical Genetics Ghent, Ghent University, Ghent 9000, Belgium
4
Cancer Research Institute Ghent (CRIG), Ghent University, Ghent 9000, Belgium
*
Author to whom correspondence should be addressed.
Academic Editors: Roel Ophoff and George A. Calin
Genes 2017, 8(3), 95; https://doi.org/10.3390/genes8030095
Received: 17 November 2016 / Revised: 15 February 2017 / Accepted: 24 February 2017 / Published: 3 March 2017
(This article belongs to the Special Issue microRNAs and Other Non-Coding RNAs in Human Diseases)
Innate and acquired chemoresistance exhibited by most tumours exposed to conventional chemotherapeutic agents account for the majority of relapse cases in cancer patients. Such chemoresistance phenotypes are of a multi-factorial nature from multiple key molecular players. The discovery of the RNA interference pathway in 1998 and the widespread gene regulatory influences exerted by microRNAs (miRNAs) and other non-coding RNAs have certainly expanded the level of intricacy present for the development of any single physiological phenotype, including cancer chemoresistance. This review article focuses on the latest research efforts in identifying and validating specific key molecular players from the two main families of non-coding RNAs, namely miRNAs and long non-coding RNAs (lncRNAs), having direct or indirect influences in the development of cancer drug resistance properties and how such knowledge can be utilised for novel theranostics in oncology. View Full-Text
Keywords: miRNA; lncRNA; cancer; chemoresistance; drug resistance; tumour; microRNA miRNA; lncRNA; cancer; chemoresistance; drug resistance; tumour; microRNA
Show Figures

Figure 1

MDPI and ACS Style

Ayers, D.; Vandesompele, J. Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance. Genes 2017, 8, 95.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop